Evidence map›Paper›PMID 40332132›Full record

SynthesisInternational journal of molecular sciences2025

Dental Implant Survival and Risk of Medication-Related Osteonecrosis in the Jaws in Patients Undergoing Antiresorptive Therapy: A Systematic Review.

Armando Crupi, Jacopo Lanzetti, Daniela Todaro, Francesco Pera, Francesco Maria Erovigni

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. The dental implant surface: a review of the past, present and future.Journal of materials science. Materials in medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Armando CrupiDepartment of Oral Rehabilitation and Maxillofacial Prosthesis, Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy.ORCID 0000-0001-9755-8083
Jacopo LanzettiDepartment of Oral Rehabilitation and Maxillofacial Prosthesis, Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy.ORCID 0000-0002-8153-7517
Daniela TodaroDepartment of Oral Rehabilitation and Maxillofacial Prosthesis, Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy.
Francesco PeraDepartment of Oral Rehabilitation and Maxillofacial Prosthesis, Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy.ORCID 0000-0002-3565-6240
Francesco Maria ErovigniDepartment of Oral Rehabilitation and Maxillofacial Prosthesis, Dental School, University of Turin, Via Nizza 230, 10126 Turin, Italy.ORCID 0000-0001-9684-3499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between antiresorptive medication and dental implant procedures remains a subject of concern complicating the decision-making process for clinicians. The aim of the study is to conduct a literature review on the relationship between dental implant placement and the incidence of osteonecrosis of the jaw (ONJ) in patients receiving antiresorptive drugs. The systematic review relied on the PRISMA statement using the PICO tool. The literature search was performed using PubMed, EBSCOhost and Scopus for RCTs, controlled clinical trials and cohort studies. The choice of reference studies was made in a blind process with a 100% agreement rate. For all included studies, quality assessment was performed. The research led to the selection of 608 results. Only five studies were included in the review. Three of the included studies were judged as having a low risk of bias. Dental implants may not be linked to a higher risk of osteonecrosis of the jaw in patients taking low-dose bone-modifying agents. The long-term survival of implants in osteoporotic patients taking oral antiresorptive medication was similar to that in a healthy population and significantly higher than in untreated controls.

Indexed as

Bisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsDental ImplantsOsteonecrosisHumansOsteoporosisRisk FactorsBone Density Conservation AgentsDental Implantsantiresorptive therapydental implantsONJperi-implant care

Identifiers

PMID40332132
PMCPMC12027229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.